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Abstract 19 
Capnocytophaga canimorsus is a dog oral commensal that causes rare but severe 20 
infections in humans. C. canimorsus was recently shown to be endowed with a capsular 21 
polysaccharide implicated in the resistance to the innate immune system of the host. 22 
Here we developed the first C. canimorsus capsular serotyping scheme. We describe 23 
nine different serovars (A to I), which allowed to type 25/25 isolates from human 24 
infections but only 18/52 isolates from dog mouths, indicating that the repertoire of 25 
capsules in the species is vast. However, three serovars only (A, B, and C) covered 88 26 
% of the human isolates tested (22/25) while they covered only 7.7 % of the dog isolates 27 
(4/52). Serovars A, B, and C were found 22.9, 14.6, and 4.2 fold respectively more often 28 
among human isolates than among dog isolates, with no geographical bias, implying 29 
that isolates endowed with these three capsular types are more virulent for humans than 30 
other isolates. Capsular serotyping would thus allow to identify virulent isolates in dogs, 31 
which could contribute to the prevention of these infections. To this end, we developed a 32 
PCR typing method based on the amplification of specific capsular genes.  33 
 34 
Introduction 35 
Capnocytophaga canimorsus are agents of septicemia that often evolve to a septic 36 
shock in spite of an adequate treatment (1). Since their discovery in 1961 (2) more than 37 
480 cases of infections were reported in the literature (for a recent review see (3)). With 38 
a mortality rate of 30 % and significant morbidity, the prognosis of C. canimorsus sepsis 39 
is poor (4, 5). Although less frequently reported, meningitis and endocarditis are also 40 
associated with C. canimorsus infections (3). The genus Capnocytophaga, which 41 
belongs to the family of Flavobacteriaceae in the phylum of Bacteroidetes comprises 42 
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 3
capnophilic species found in the oral cavities of human and domestic animals. The dogs 43 
and cats mouth hosts C. canimorsus (6), formerly dysgonic fermenter-2 (DF-2), C. 44 
cynodegmi (1, 6) and the newly described C. canis (7) and “C. stomatis” (8) but only C. 45 
canimorsus is associated with severe human infections (1, 7, 8). According to studies 46 
carried out in different countries, the prevalence of C. canimorsus ranges from 19 to 47 
74% in dogs and 21 to 57% in cats (9-13). However, these figures may include C. canis 48 
and “C. stomatis” that were separated recently from the C. canimorsus species. 49 
Transmission to humans mostly occurs through dog (97%) or cat (3%) bites, scratches, 50 
licks, or simple contact (3, 14). The prevalence of C. canimorsus infections was 51 
estimated at 0.5 and 0.63 case per million inhabitants per year in Denmark (5) and in the 52 
Netherlands (15) respectively but a recent study in the Helsinki area (Finland) estimated 53 
the prevalence as high as 4.1 cases per million inhabitants per year (16). C. canimorsus 54 
infections could thus be under-diagnosed due to the fastidious and slow growth of C. 55 
canimorsus in culture (1, 17). In addition, the initial clinical manifestations of C. 56 
canimorsus infections are not specific and their onset can be as late as 8 days after 57 
contact with a dog (3, 5). The median age of patients is comprised between 52 and 59 58 
years and a male to female ratio of 3/2 is generally observed (3, 5, 16). Splenectomy 59 
and alcohol abuse are common predisposing factors but up to 40% of patients 60 
presented no obvious risk factor (18) implying that C. canimorsus cannot solely be 61 
considered as an opportunistic pathogen. 62 
C. canimorsus strain 5 (Cc5, BCCM/LMG 28512), a strain isolated from a fatal 63 
septicemia (19) has a lipooligosaccharide (LOS) and a capsular polysaccharide (CPS) 64 
which are genetically and biochemically related (20). The CPS plays a key role in the 65 
innate immunity evasion by conferring Cc5 its resistance to phagocytosis by 66 
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macrophages, to polymyxin B, and to 10 % human serum (20). In addition to being 67 
recognized virulence factors for both Gram-negative and -positive bacteria (for review 68 
see (21)), CPS are also useful to serotype bacteria and to identify virulent isolates (22, 69 
23). Here we show that 25 isolates of C. canimorsus out of 25 from a collection of 70 
isolates from human infections are endowed with a CPS and that those polysaccharide 71 
structures present a limited variability, with 3 dominant capsular serovars. In addition, a 72 
clear enrichment of these dominant capsular serovars was found in human isolates 73 
(22/25) as compared to isolates from dog mouths (4/52). Finally, we show that PCR 74 
typing can be used to detect these serovars more virulent for humans. This study paves 75 
the way to prevention of these dramatic infections.  76 
 77 
Material and methods 78 
Bacterial strains, isolates, and culture conditions 79 
Bacterial strains and isolates used in this study are listed in the Supplementary Tables 80 
S1 and S2. C. canimorsus were grown on heart infusion agar (HIA; BD Difco, Franklin 81 
Lakes, NJ, USA) supplemented with 5% sheep blood (SB; Oxoid, Basingstoke, UK) 82 
plates (SB plates) for 48h at 37°C with 5% CO2. Escherichia coli were routinely grown in 83 
lysogeny broth (LB; Invitrogen, Waltham, MA, USA) at 37°C. Antibiotics used as 84 
selective agents were added at the following concentrations: 100 μg/mL ampicillin 85 
(AMP) and 50 μg/mL kanamycin (KAN) for E. coli and 20 μg/mL gentamicin (GEN), 10 86 
μg/mL erythromycin (ERY), and 10 μg/mL cefoxitin (FOX) for C. canimorsus. Unless 87 
otherwise stated products were purchased from Sigma-Aldrich (Darmstadt, Germany). 88 
 89 
Anti-sera production and adsorption 90 
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 5
Bacteria were grown for 2 days on SB plates supplemented with GEN, gently scraped 91 
from the agar, resuspended and washed in PBS. Bacteria were fixed overnight in 0.3% 92 
paraformaldehyde (PFA), washed in PBS and inoculated to a rabbit to generate 93 
polyclonal sera. Sera were generated at the University of Namur (Belgium) or at the 94 
Centre d’économie rurale (CER Groupe; Aye, Belgium). The respective Animal Welfare 95 
Committees approved the animal handling and procedures. Polyclonal sera were 96 
adsorbed by incubation with an excess of PFA-fixed non-capsulated mutant bacteria 97 
unless stated otherwise in results. Incubations were done on a rotating wheel at room 98 
temperature (RT) and repeated four times. Bacteria were removed by repeated 99 
centrifugations. Adsorption efficacy was assessed by immunofluorescence as follow. 100 
Glass coverslips were coated with poly-D-lysine (10 μg/mL in PBS, for 1 hour at 37°C), 101 
washed and incubated for 30 min at 37°C with 300 μL of a bacterial suspension adjusted 102 
to an OD600 of 0.25. Coverslips were then washed and bacteria were fixed for 15 min 103 
with 4% PFA. Coverslips were washed again and blocked with 1% bovine serum 104 
albumin (BSA) for 1 hour at RT. Bacteria were stained with the adsorbed sera (1/1000 in 105 
PBS) for 1 hour at RT followed by an incubation with an Alexa Fluor 488-coupled donkey 106 
anti-rabbit antibody (1/5000 in PBS; Life technologies, Waltham, MA, USA) or a Texas 107 
Red coupled goat anti-rabbit antibody (1/1000 in PBS, Southern Biotech, Birmingham, 108 
AL, USA) for 45 min. Coverslips were mounted using mowiol mounting medium and 109 
images were acquired with an Axio Imager.Z1 (Zeiss, Oberkochen, Germany) and 110 
analyzed using Zen 2012 software (Zeiss). 111 
 112 
Mutagenesis by allelic exchange  113 
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Mutagenesis of Cc6, Cc9, and Cc12 strains was performed as previously described (24). 114 
The C. canimorsus deletion mutants and the E. coli strains used are listed in the 115 
Supplementary Table S2. Briefly, replacement cassettes with flanking regions spanning 116 
approximately 500 base pairs (bp) homologous to regions directly framing targeted 117 
genes were constructed with a three-fragment overlapping PCR strategy. First, two 118 
PCRs were performed on 100 ng of Cc6, Cc9, or Cc12 genomic DNA with primers 1.1 119 
and 1.2 for the upstream flanking regions and with primers 2.1 and 2.2 for the 120 
downstream regions (Supplementary Table S3). Primers 1.2 and 2.1 contained an 121 
additional 5′ 20-nucleotide extension homologous to the ermF insertion cassette. The 122 
ermF resistance cassettes were amplified from plasmid pMM13 (24) DNA, with primers 123 
3.1 and 3.2. All three PCR products were cleaned and then mixed in equal amounts for 124 
PCR using Phusion polymerase (Finnzymes, Espoo, Finland). The initial denaturation 125 
was at 98°C for 2 min, followed by 12 cycles without primers to allow annealing and 126 
elongation of the overlapping fragments (1 cycle consists of 98°C for 30 s, 50°C for 40 s, 127 
and 72°C for 2 min). After the addition of external primers (primers 1.1 and 2.2), the 128 
program was continued with 20 cycles (1 cycle consists of 98°C for 30 s, 50°C for 40 s, 129 
and 72°C for 2 min 30 s) and finally 10 min at 72°C. Final PCR products consisting of 130 
locus::ermF insertion cassettes were then digested with PstI and SpeI (New England 131 
Biolabs, Ipswich, MA, USA) for cloning into the appropriate sites of the C. canimorsus 132 
suicide vector pMM25 (24). The resulting plasmids were transferred by RP4-mediated 133 
conjugative DNA transfer from E. coli S17-1 to the corresponding C. canimorsus strains 134 
to allow integration of the insertion cassette. Transconjugants were then selected for the 135 
presence of the ermF cassette on erythromycin-containing plates and checked for 136 
sensitivity to cefoxitin. Deletion of the appropriate regions was verified by PCR. 137 
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 138 
Western blotting of polysaccharide structures 139 
Bacteria were harvested by gently scraping colonies off the agar surface of GEN SB 140 
plate and resuspended in PBS. Bacteria suspensions were adjusted to an OD600 of 1 in 141 
PBS. 750 μL of the suspension were pelleted and resuspended in 125 μL loading buffer 142 
(1% sodium dodecyl sulphate (SDS), 10% glycerol, 50mM dithiothreitol, 0.02% 143 
bromophenol blue, 45mM Tris (pH6.8)). Samples were heated for 10 min at 99°C. 144 
Proteinase K (VWR Chemicals, Radnor, PA, USA), was added to a final concentration of 145 
50 μg/mL and samples were incubated overnight at 37°C. Subsequently, samples were 146 
heated for 10 min at 99°C and proteinase K was added again at the same final 147 
concentration. Samples were incubated for 3 hours at 55°C, heated for 5 min at 99°C 148 
and loaded on a 12% polyacrylamide gel. After SDS-PAGE (polyacrylamide gel 149 
electrophoresis), proteinase K resistant structures were transferred on a nitrocellulose 150 
membrane (GE Healthcare, Chicago, IL, USA). Membranes were blocked and incubated 151 
with polyclonal crude or adsorbed sera (dilutions ranging from 1/400 to 1/8000) followed 152 
by incubation with a horseradish peroxidase (HRP)-coupled goat anti-rabbit polyclonal 153 
antibody (1/2000; Dako Agilent Technologies, Santa Clara, CA, USA). Membranes were 154 
revealed using a chemiluminescent substrate (KLP, Gaithersburg, MD, USA) on an 155 
Amersham Imager 600 (GE Healthcare). Blocking and all incubations were conducted in 156 
5% non-fat dry milk diluted in PBS 0.05% Tween. 157 
 158 
Capsular serotyping by ELISA  159 
Bacteria suspensions were adjusted to an OD600 of 0.5 and were killed by an incubation 160 
of 30 min at 70°C. Heat-killed bacteria suspensions were used to coat 96 well plates 161 
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 8
(ThermoScientific, Waltham, MA, USA) overnight at 4°C. The next day plates were 162 
washed to remove unfixed bacteria and blocked for 1 hour at RT with 1% BSA in PBS. 163 
Plates were washed and incubated with adsorbed polyclonal serum (1/1000 to 1/5000 in 164 
PBS) for 1 hour at RT. Plates were washed again and incubated with HRP-coupled goat 165 
anti-rabbit polyclonal antibody for 1 hour at RT (Dako Agilent Technologies; 1/2000 in 166 
PBS). Plates were then washed and revealed using 3,3’,5,5’-Tetramethylbenzidine 167 
(TMB) as a chromogenic substrate. 168 
 169 
Capsular serotyping by PCR  170 
Bacteria were grown on SB plates supplemented with GEN and a single colony was 171 
resuspended in 100 μL ddH2O and heated for 15 min at 98 °C. Two microliters were 172 
used as template for amplification. PCR detection was performed using the Promega Go 173 
Taq® G2 polymerase (Madison, WI, USA) under the following conditions: an initial 174 
denaturation at 95°C for 4 min, followed by 35 cycles of denaturation at 95°C for 30 s, 175 
annealing at 52°C for 45 s, extension at 72°C for 1 min and 30 s, and a final extension at 176 
72°C for 7 min. 177 
 178 
Synteny analysis 179 
Synteny statistics were obtained using the MicroScope PkGDB synteny statistics tool 180 
(https://www.genoscope.cns.fr/agc/microscope/home/index.php) (25). Putative 181 
orthologous relations based on the bi-directional best hit (BBH) criterion were 182 
considered for at least 35% of sequence identity on 80% of the length of the smallest 183 
protein. For the synteny analysis, all possible kinds of chromosomal rearrangements are 184 
allowed (inversion, insertion/deletion) and the gap parameter, representing the 185 
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maximum number of consecutive genes which are not involved in a synteny group, is set 186 
to five genes. 187 
 188 
Statistical analysis 189 
Statistical significance was evaluated by Fisher’s exact tests using the BiostaTGV 190 
website (https://marne.u707.jussieu.fr/biostatgv).  191 
 192 
Accession numbers 193 
Accession numbers of genes used in this study are listed in Supplementary Table S4.  194 
 195 
Results 196 
Capsular serotyping identifies 5 serovars in a collection of C. canimorsus isolated 197 
from human infections 198 
The prevalence of the capsular serovar of strain Cc5 was tested in a collection of 25 C. 199 
canimorsus isolated from human infections (Supplementary Table S1). Whole bacteria 200 
were digested with proteinase K and bacterial polysaccharides were analyzed by 201 
western blot using an anti-serum directed against Cc5 bacteria and adsorbed with the 202 
non-capsulated Cc5 transposon mutant Y1C12 (20, 26). The serum recognized a high 203 
molecular weight (MW) band (>250 kDa) in the extracts from Cc5 and from ten other 204 
isolates, namely Cc1 (BCCM/LMG 11511; CCUG 17234; strain P810; strain SSI P810), 205 
Cc2, Cc3, Cc10 (BCCM/LMG 11541, CCUG 24741, ATCC 35978, CDC C8936), Cc13, 206 
Cc15, Cc21 (CCUG 60839), Cc22 (CCUG 20318), Cc24 (CCUG 67384), and Cc25 207 
(CCUG 66222) (Figure 1A). Since this band was identified as the CPS of Cc5 (20), we 208 
concluded that the capsular serovar of Cc5 was shared with these 10 isolates 209 
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 10
representing 44% of our collection of human isolates. We named this capsular serovar 210 
A. 211 
To determine the capsular serovar of the 14 non-A human isolates, 9 new anti-sera were 212 
raised and tested by western blot on polysaccharide extracts from these 14 isolates. The 213 
antisera raised against Cc6, Cc9 (BCCM/LMG 11510, CCUG 12569, CDC A3626), Cc12 214 
(type strain, ATCC 35979, CDC 7120, CCUG 53895), and Cc4 allowed detecting a high 215 
MW polysaccharide, most likely corresponding to a CPS (Figure 1) in all the 14 isolates. 216 
The anti-Cc6 serum recognized a high MW polysaccharide structure in Cc6 but also in 217 
Cc8, Cc11, Cc16, Cc17, Cc18, and Cc23 (CCUG 48899) (Figure 1B). This serovar, 218 
named B, had thus a prevalence of 28% in our collection of human isolates, with 7 219 
isolates positive out of 25. The anti-Cc9 serum recognized a high MW polysaccharide 220 
structure in Cc9, Cc14, Cc19, and Cc20 (CCUG 55909) (Figure 1C). This serovar, 221 
named C had thus a prevalence of 16%. The anti-Cc12 serum recognized a high MW 222 
polysaccharide structure in Cc12 and Cc7 (Figure 1D). The prevalence of this serovar, 223 
named D, was of 8%, thus more limited than that of serovars A, B, and C. Finally, the 224 
anti-Cc4 serum recognized a high MW polysaccharide band only in Cc4. This serovar 225 
had thus a prevalence of only 4% and was named E (Figure 1E). 226 
In order to confirm that the high MW bands recognized are CPS, we next attempted to 227 
generate non-capsulated deletion mutants of Cc6, Cc9, Cc12, and Cc4 (Supplementary 228 
Table S2). Since the capsule of Cc5 is made of the same sugars as the LOS O-chain, 229 
we decided to generate rough non-capsulated mutants. To this aim we sequenced the 230 
genomes of the isolates Cc6, Cc9, and Cc4 and used the previously published genome 231 
of Cc5 (GenBank: CP002113) (27) and draft genome of Cc12 (GenBank: 232 
CDOE00000000.1) (28). Homologs of Cc5 wbuB gene (Ccan_23370), which is the gene 233 
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 11
mutated in the LOS/CPS mutant Y1C12 and encodes a N-acetyl-fucosamine (FucNAc) 234 
transferase (20), were found in the genomes of Cc6 (Cc6_1430029) and Cc9 235 
(CCAN9_740038) but not in those of Cc12 and Cc4. In the latter genomes we identified 236 
homologs of Cc5 wbtA (Ccan_23400) that is mutated in the LOS/CPS mutant Y1D1 (20) 237 
of Cc5 and encodes an UDP-N-acetylglucosamine 4,6-dehydratase (CCAN12_760057, 238 
and CC4_530070 respectively) (20). The wbuB genes were thus mutated in Cc6 and 239 
Cc9 while gene wbtA was mutated in Cc12. The polysaccharide extracts from the 240 
mutants of Cc6, Cc9, and Cc12, analyzed by western blot with the anti-Cc6, anti-Cc9, 241 
and anti-Cc12 sera, did not contain the high MW band indicating that it was indeed a 242 
CPS (Figure 1B, C and D). Gene wbtA from Cc4 could not be mutated despite several 243 
attempts and hence we could not formally prove that the high MW polysaccharide is a 244 
CPS related to the LOS. Nevertheless, the presence of a wza homolog, encoding for the 245 
capsular transporter across the outer membrane, suggests that Cc4 is indeed endowed 246 
with a capsule. 247 
We thus conclude that the 25 C. canimorsus human isolates of our collection are all 248 
endowed with a CPS and that the antigenic repertoire of these CPS is limited since 88% 249 
of the isolates (22/25) belong to serovars A, B, and C. Interestingly, the distribution of 250 
serovars A, B, and C is not affected by a geographical bias since each serovar was 251 
found in isolates from at least three different countries (Supplementary Table S5).  252 
 253 
Prevalence of capsular serovars A, B, and C among C. canimorsus isolated from 254 
dog mouths  255 
We next assessed the prevalence of the capsular serovars A to E among a collection of 256 
52 isolates of C. canimorsus from dog mouths (Supplementary Table S1) (7). To this 257 
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 12
aim we set up an ELISA screening using entire heat-killed bacteria. Since we needed 258 
sera that were specifically recognizing the CPS, for serovar A, we used the Y1C12-259 
adsorbed anti-Cc5 serum; for serovars B, C, and D, we adsorbed the crude anti-Cc6, 260 
anti-Cc9, and anti-Cc12 sera with Cc6 wbuB, Cc9 wbuB, and Cc12 wbtA mutant 261 
bacteria respectively. Due to the lack of a non-capsulated Cc4 mutant strain, we 262 
adsorbed the anti-Cc4 serum (serovar E) with the 24 other human isolates belonging to 263 
different capsular serovars (Figure 1E). The efficacy of the different adsorptions was 264 
validated by immunofluorescence staining and microscopy analysis (Supplementary 265 
Figure S1). The five adsorbed sera were then used to test our collection of dog isolates 266 
by ELISA. The reactivity of each isolate was calculated with respect to that of the type 267 
strain of each serovar (Cc5 for A, Cc6 for B, Cc9 for C, Cc12 for D, and Cc4 for E). The 268 
non-capsulated mutant strains were used as negative controls. The results of the 269 
screening are summarized in Table 1. Only two isolates, CcD68 and CcD105, were 270 
positive for serovar A with a reactivity of 43% ± 7 and 107% ± 28 respectively. The high 271 
MW polysaccharidic structures of these isolates were analyzed by western blot and only 272 
the strongly reacting CcD105 displayed a serovar A capsule (Supplementary Figure 273 
S2A). For serovar B, only isolate CcD68 was found to be positive (110% ± 11) by ELISA 274 
and by western-blot (Supplementary Figure S2B). For serovar C, isolates CcD43 and 275 
CcD130 were positive by ELISA (86% ± 5 and 108% ± 26 reactivity respectively) and 276 
western blot (Supplementary Figure S2C). For serovar D, three isolates were strongly 277 
recognized by ELISA and confirmed by western blot: CcD16 (86% ± 14), CcD89 (95% ± 278 
9), and CcD117 (99% ± 12) (Supplementary Figure S2D). Finally for serovar E, isolate 279 
CcD96 displayed a high reactivity of 118% ± 37 and isolates CcD20 and CcD106 280 
displayed intermediate reactivities of respectively 57% ± 24 and 59% ± 24 while some 281 
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 13
other isolates presented a limited reactivity. All the isolates with a value equal or higher 282 
than 30 % were checked by western blot and only one isolate, CcD96, was confirmed to 283 
belong to serovar E (Supplementary Figure S2E). The results from the ELISA and the 284 
western blot analyses are summarized in Figure 2. While all the human isolates 285 
belonged to serovars A, B, C, D, or E, 84.6% of the dog isolates were left non-typeable. 286 
In conclusion, the prevalence of serovar A was 22.9 fold higher in human isolates than in 287 
dog isolates (Fisher’s exact test, p=6.45.10-6) while the prevalence of serovar B was 288 
14.6 fold higher (Fisher’s exact test, p=0.00123). A 4.2 fold increase was found for the 289 
serovar C, but it was not statistically significant (Fisher’s exact test, p=0.0831). Finally, 290 
there was no significant difference in the prevalence of serovars D and E (p values of 291 
0.657 and 0.547 respectively in Fisher’s exact test).  292 
 293 
There is a high capsular variability among the isolates from dog mouths  294 
To investigate the variability of the capsular serovars in the 44 untyped dog isolates, we 295 
generated sera against 4 isolates randomly chosen (CcD37, CcD63, CcD101, and 296 
CcD129). Since we could not generate uncapsulated mutants because the genomes of 297 
these isolates are not available, the anti-sera were adsorbed using a mix of the 25 C. 298 
canimorsus human isolates. After validating the adsorption efficacy by 299 
immunofluorescence (Supplementary Figure S1) we screened the 52 dog isolates by 300 
ELISA (Table 1). The adsorbed anti-CcD37 serum reacted not only with CcD37 but also 301 
with CcD13, CcD52, CcD113, CcD118, and CcD124 with reactivities comprised between 302 
83 and 111%. All these reactions were confirmed by western blot (Supplementary 303 
Figure S2F). This serovar, named F, had thus a prevalence of 11.5% among dog 304 
isolates (6/52). The adsorbed anti-CcD63 reacted with the CPS of CcD63 but with no 305 
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other isolate (Supplementary Figure S2G). This serovar, G, had thus a reduced 306 
prevalence of 1.9% (1/52). The adsorbed anti-CcD101 serum reacted with only one 307 
other isolate, (CcD53) but this isolate did not show any CPS (Supplementary Figure 308 
S2H). This serovar, H, had thus a prevalence of 1.9 % (1/52). Finally the adsorbed anti-309 
CcD129 serum reacted by ELISA and western blot with the CPS of CcD129 and CcD33 310 
(Supplementary Figure S2I). This serovar, I, had thus a prevalence of 3.8% (2/52). 311 
There were no significant differences in the prevalence of serovars F, G, H, and I 312 
between dog and human isolates (p values of 0.169 for F and 1 for G, H, and I in 313 
Fisher’s exact test), but while five serovars covered the 25 human isolates (100 %), nine 314 
serovars covered only 18 dog isolates (34.6 %) (Figure 2). This result indicates there is 315 
a higher variability of capsular serovars among dog isolates than among human isolates. 316 
 317 
Detection of the capsular serovars A to E by PCR 318 
Our data so far clearly show that the capsular serotyping could help identifying dogs 319 
hosting C. canimorsus isolates that are more virulent for humans than others. Since 320 
immunological screening methods are somehow difficult to implement in diagnostics 321 
laboratories, we tried to develop a PCR-based method using different oligonucleotides 322 
couples that would allow the identification of the 5 serovars found among human 323 
isolates. 324 
We thus first compared the capsule and LOS biosynthesis loci in the seven available 325 
genomes of C. canimorsus isolates belonging to the five serovars (Cc5, Cc2, Cc6, Cc11, 326 
Cc9, Cc12, and Cc4) (Figure 3). Looking for a gene that was specific to serovar A 327 
isolates (Cc5, Cc2), we identified an A4GalT-like glycosyltransferase gene (Ccan_23210 328 
and CCAN2_1920004 in Cc5 and Cc2 respectively) (20). Two amplimers were designed 329 
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and our complete C. canimorsus collection was tested by PCR. As shown in Figure 4 330 
and Table 2, this analysis detected all serovar A isolates (11 human- and one dog-331 
isolates) and no other isolate.  332 
Regarding serovar B, we could not identify any gene that was unique to the Cc6 and 333 
Cc11 genomes (Figure 3). However, while genes CC6_1430035 and CCAN11_10027, 334 
both encoding a putative family 1 glycosyltransferase, were exactly conserved in Cc5 335 
(serovar A), they were not in Cc2 (also serovar A).  Aligning CC6_1430035 and 336 
CCAN11_10027 with their homologs from Cc2 (CCAN2_1430008) and Cc9 (serovar C) 337 
(CCAN9_740032) (20) revealed a difference in the 16 base pairs immediately 338 
downstream of the start codon (Supplementary Figure S3). Since both serovar B 339 
isolates (Cc6 and Cc11) had the exact same gene sequence, shared by only one of the 340 
two serovar A isolates (Cc5), we tested whether the exact same gene sequence would 341 
not be shared by all serovar B isolates. We thus designed two oligonucleotides to 342 
amplify this specific gene region and, as shown in Figure 4 and Table 2, by this PCR, 343 
we could indeed detect all the 7 serovar B human isolates as well as the only serovar B 344 
dog isolate (CcD68). As expected we could also detect Cc5 but two other serovar A 345 
isolates, namely Cc15 and Cc24, as well. Surprisingly, the PCR gave a positive result for 346 
one dog isolate (CcD57) that did not belong to any of the 5 serovars (Table 1, 347 
Supplementary Figure S2E and Supplementary Figure S4A) and thus represents a 348 
false positive. Nevertheless, with this PCR we could detect all serovar B isolates of our 349 
collection and this analysis, if combined with the one specific for the serovar A, allowed 350 
the discrimination between serovars A and B. Indeed, serovar B isolates are positive for 351 
PCR B but negative for PCR A. 352 
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Regarding serovar C, we could not identify any gene unique to the Cc9 genome but 353 
CCAN9_740031, encoding a putative O antigen polymerase (wzy) had an homolog only 354 
in one serovar A isolate, namely Cc2 (Figure 3). We thus tested by PCR whether this 355 
gene would be shared by all serovar C isolates. As shown in Figure 4 and Table 2, we 356 
could detect all serovar C isolates namely the 4 from humans (Cc9, Cc14, Cc19) and 357 
Cc20) as well as the two from dogs (CcD43 and CcD130). This PCR thus allows the 358 
detection of the serovar C isolates and, if combined with the PCR for the serovar A, to 359 
discriminate between these two serovars. Indeed, serovar C isolates are positive for 360 
PCR C but negative for PCR A. 361 
Concerning serovar D, the Cc12 LOS/CPS locus was previously shown to be very 362 
divergent from the ones of serovars A, B, and C isolates with a limited number of 363 
conserved genes (20) (Figure 3). We chose to amplify gene CCAN12_760043 encoding 364 
a putative lipopolysaccharide biosynthesis O-acetyl transferase (WbbJ) that had no 365 
homologs in all the other serovars loci. As shown in Figure 4 and Table 2, this PCR 366 
exclusively detected the serovar D isolates and it detected them all (Cc12, Cc7, CcD16, 367 
CcD89, and CcD117). 368 
Finally, as for Cc12, the serovar E strain Cc4 LPS/CPS locus strongly diverged from the 369 
ones of all the other serovars (Figure 3). We thus chose as target gene a Cc4 unique 370 
gene, namely CC4_530066, encoding a glycosyltransferase 1 family protein. As shown 371 
in Figure 4 and Table 2, this PCR detected the Cc4 and CcD96 serovar E isolates. 372 
Among the other isolates, only CcD10 gave a positive result although it did not react with 373 
the E antiserum (Table 1 and Supplementary Figure S4B) and could thus be 374 
considered as a false positive. In summary, in order to determine the serovar of a C. 375 
canimorsus isolate, the five (A, B, C, D, and E) PCR should be performed and the 376 
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results interpreted as follows: i) all isolates that are positive for PCR A belong to serovar 377 
A; ii) isolates that are positive for PCR B belong to serovar B if they are not positive for 378 
PCR A; iii) isolates that are positive for PCR C are serovar C if they are not positive for 379 
PCR A; iv) isolates that are positive for PCR D are serovar D; v) isolates that are 380 
positive for PCR E are serovar E (Table 2 and Table 3) 381 
In conclusion, capsular serotyping can be done by PCR (Table 2 and Table 3) with a 382 
very limited margin of error (2 false positive dog isolates). 383 
Next, given the higher prevalence of serovars A, B, and C (22/25) among human 384 
isolates, we decided to develop a PCR that would allow to detect all serovar A, B, and C 385 
isolates. To this aim, taking advantage of the high similarity among the LOS/CPS loci of 386 
the isolates belonging to serovars A, B, and C, we designed two amplimers specific to 387 
the conserved region of the putative glycosyltransferase wfdR orthologs genes of 388 
serovar A (Ccan_23240 in Cc5 and CCAN2_1430002 in Cc2), serovar B (CC6_1430040 389 
in Cc6 and CCAN11_2010013 in Cc11), and serovar C (CCAN9_740027). As shown in 390 
Figure 4 and Table 2, by this PCR we could detect all the isolates belonging to serovars 391 
A, B, and C. Among the non-A, -B, or -C isolates, only CcD77 gave an amplification but 392 
not of the same size (Figure 4). This PCR, allowing to identify fast and specifically all 393 
the C. canimorsus isolates belonging to serovars A, B, or C (Table 3) could thus be a 394 
valuable tool in terms of prevention. 395 
 396 
Discussion 397 
Here we show that all 25 out of 25 C. canimorsus isolated from human infections and 18 398 
dog isolates out of 18 tested are endowed with a CPS. We thus confirm our previous 399 
observation where a capsular-like polysaccharide structure was found in ten human 400 
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isolates (20). This result further reinforces the commonality of the presence of a CPS in 401 
C. canimorsus. In addition, we developed a serotyping scheme based on the capsular 402 
antigens and we described nine serovars (A to I). The LOS and CPS synthesis are 403 
genetically linked in strain Cc5, resulting in similar polysaccharide units compositions in 404 
both structures (20). For serovars B to I, we also found shared epitopes between the 405 
CPS and LOS (data not shown). Even more, the antiserum directed against the 406 
CPS/LOS from serovar C recognized the LOS but not the CPS from some serovar A 407 
isolates (data not shown), revealing some complexity in the CPS/LOS relation. Because 408 
of this complexity and because it is the CPS rather than the LOS that impacts the host-409 
pathogen interaction (20), we based our typing scheme on the CPS only. However, 410 
because of this cross-reaction, the distinction between serovars A and C must be done 411 
by western blotting and not by immuno-fluorescence or ELISA. Because western blotting 412 
is a tedious technique for clinical laboratories, we set up a PCR method for the capsular 413 
serotyping. The cross-reaction between the LOS of serovar A and some strains of 414 
serovar C also appeared when the typing was done by PCR but combining the two PCR 415 
reactions allows to determine the serovar without any ambiguity. Further work will be 416 
required to understand the molecular mechanisms underlying these LOS cross-reactions 417 
but carbohydrate chemistry always represents a long-term project.  418 
The nine serovars described covered only 18 dog isolates out of 52 tested while five 419 
serovars only covered the 25 human isolates. Thus, there was a high variety of capsular 420 
serovars among dog isolates. In contrast, only three serovars (A, B, and C) covered 88 421 
% of the human isolates tested (22/25) while they covered only 4 dog isolates (7.7 %). 422 
There was thus a very strong enrichment of serovars A, B, and, to a lesser extend C in 423 
human isolates as compared to dog ones. Interestingly, these three dominant capsular 424 
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serovars were not restricted to a geographical area but were rather distributed 425 
worldwide. This observation clearly indicates that the strains belonging to serovars A, B, 426 
and, possibly C, are more virulent for humans than strains from the other serovars. This 427 
sets the bases for the prevention of these severe infections. To this aim, one could 428 
envision the detection of potentially more dangerous dogs using a PCR reaction carried 429 
out directly on the dog’s saliva and monitoring simultaneously the three more virulent 430 
serovars. Our results on collection isolates have indeed shown that PCR is reliable with 431 
a very limited number of false positives and, in our experience, no false negative. 432 
Owners of a dog hosting a serovar A, B, or C strain should be educated to limit the 433 
contact with the dog’s saliva and if a bite or a lick occurs, to apply strict hygiene 434 
measures. In addition, splenectomized and more generally immunocompromized 435 
persons should not consider adopting a dog hosting a virulent C. canimorsus strain. 436 
Ideally, more human isolates should be serotyped to reinforce the correlation between 437 
some capsular serovars and human infections but their collection is very tedious due to 438 
the rarity of the disease and the fastidious character of these bacteria. 439 
There was no significant difference in the distribution of capsular serovars D and E 440 
among dog (4/52) and human isolates (3/25), which suggests that they are probably not 441 
more virulent than most dog strains. This observation leads to the conclusion that, while 442 
a majority of the patients (88 % of our sample) are infected with virulent strains (A, B, 443 
possibly C), a minority of patients (12 % of our sample) could have been infected by 444 
strains that belong to a less virulent serovar (D and E). This is consistent with the fact 445 
that some patients were obviously at risk while others had no history of immune 446 
deficiency. In agreement with this hypothesis, the patient infected with Cc4 (serovar E) 447 
was highly immunocompromised (29) and the patient infected with Cc12 (serovar D) 448 
 o
n
 M
ay 4, 2017 by BIBLIO
THEQUE UNIVERSITAIRE
http://jcm.asm.org/
D
ow
nloaded from
 
 20
was splenectomized (2) (Supplementary Table S1). Hence, splenectomized and more 449 
generally immunocompromised persons should be extremely cautious when interacting 450 
with dog hosting C. canimorsus regardless of the serovar of the latter. 451 
It is likely that it is the capsule itself that confers an enhanced virulence to serovars A, B, 452 
and C, as is classical for other pathogens (21). In support of this, the capsule of the type 453 
strain Cc5 has been recently shown to provide resistance to phagocytosis by 454 
macrophages, to killing by 10% human serum and to killing by the cationic antimicrobial 455 
peptide polymyxin B (20). These results suggest that the serovar A CPS could indeed 456 
participate to the innate immune evasion in humans. Ideally, these in vitro data should 457 
be reinforced by in vivo studies but the lack of a relevant sepsis animal model to study 458 
C. canimorsus infections prevents such confirmation. Further in vitro work could 459 
determine if the capsular serovars A, B, and C provide the strains a higher resistance to 460 
the innate immune system. However, we cannot exclude that other virulence factors 461 
could be genetically linked to some capsular serovars. It would thus be interesting to 462 
compare the whole genomes looking for genes that would be shared in serovars A, B, 463 
and C strains and absent in serovars F, G, H, and I strains. 464 
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Figure 1. Capsular serotyping of C. canimorsus isolates from human infections. 563 
Western blot analysis of proteinase-K treated lysates of C. canimorsus human isolates 564 
using the following sera: Y1C12 adsorbed anti-Cc5 (A), anti-Cc6 (B), anti-Cc9 (C), anti-565 
Cc12 (D), and anti-Cc4 (E). Non-capsulated mutants Cc5 Y1C12, Cc6 ΔwbuB, Cc9 566 
ΔwbuB, and Cc12 ΔwbtA were used as controls in panels A, B, C, and D respectively. 567 
Numbers correspond to molecular mass markers in kDa. 568 
 569 
Figure 2. Prevalence of capsular serovars A to I in C. canimorsus isolated from 570 
human infections and dog mouths. Summary of capsular serovars A to I prevalence 571 
in human (A) or dogs (B) isolates. 572 
 573 
Figure 3. Synteny analysis of LOS/CPS loci in the A, B, C, D, E capsular serovars.  574 
Comparison of the LOS/CPS-biosynthesis and transport genetic loci of the seven C. 575 
canimorsus isolates whose genomes were sequenced. The boxes indicate different 576 
genomic loci. Homologs of the Cc5 genes are indicated in grey. The genes amplified by 577 
the A, B, C, D, and E serovar specific PCR are indicated in green, blue, orange, black, 578 
and yellow respectively. The target genes amplified by the ABC serovars specific PCR 579 
are in red. Genes indicated in white are isolate specific genes likely involved in 580 
LOS/CPS biosynthesis. The hatched pattern indicates genes likely unrelated to 581 
LOS/CPS biosynthesis and transport. Fragmented genes are marked with (f). Note that 582 
the genomes of Cc2, Cc4, Cc6, Cc9, Cc11, and Cc12 are draft genomes. For the sake 583 
of simplicity genes are not represented to scale.  584 
 585 
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Figure 4. Capsular typing by PCR. PCR detection of capsular serovars A, B, C, D, and 586 
E in C. canimorsus human and dog isolates using the oligonucleotides given in Table 587 
S3. C. canis (type strain CcD38, LMG 29146, DSM 101831) and C. cynodegmi (type 588 
strain Ccyn ATCC 49044) were used as negative controls. 589 
 590 
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Table 1: Capsular serotyping of C. canimorsus dog isolates by ELISA 591 
 592 
Strain/ 
Isolate 
Capsular serovar 
A B C D E F G H I 
Cc5 100 ± 0 20 ± 8 27 ± 11 24 ± 6 17 ± 2 13 ± 4 14 ± 5 10 ± 4 13 ± 5
Cc5 
Y1C12 14 ± 6 nd nd nd nd nd nd nd nd
Cc6 32 ± 7 100 ± 0 24 ± 12 20 ± 4 13 ± 2 14 ± 6 12 ± 3 11 ± 4 14 ± 7
Cc6 
ΔwbuB nd 14 ± 7 nd nd nd nd nd nd nd
Cc9 15 ± 3 17 ± 7 100 ± 0 22 ± 4 17 ± 5 14 ± 5 13 ± 4 10 ± 3 14 ± 4
Cc9 
ΔwbuB nd nd 20 ± 7 nd nd nd nd nd nd
Cc12 19 ± 7 15 ± 5 23 ± 8 100 ± 0 18 ± 0 14 ± 5 15 ± 5 10 ± 3 13 ± 5
Cc12 
ΔwbtA nd nd nd 20 ± 5 nd nd nd nd nd
Cc4 16 ± 3 14 ± 3 30 ± 10 26 ± 5 100 ± 0 13 ± 5 13 ± 4 10 ± 2 13 ± 5
CcD3 18 ± 7 11 ± 4 18 ± 5 19 ± 3 14 ± 6 10 ± 3 12 ± 1 15 ± 4 12 ± 6
CcD5 17 ± 4 13 ± 8 16 ± 4 22 ± 4 13 ± 6 11 ± 5 13 ± 2 14 ± 6 14 ± 6
CcD6 18 ± 10 11 ± 5 20 ± 7 18 ± 3 15 ± 7 11 ± 3 14 ± 2 17 ± 4 16 ± 10
CcD10 17 ± 8 12 ± 5 18 ± 3 17 ± 2 17 ± 5 10 ± 1 14 ± 2 15 ± 6 14 ± 6
CcD13 16 ± 7 11 ± 5 21 ± 4 17 ± 2 12 ± 5 99 ± 1 12 ± 1 13 ± 4 12 ± 5
CcD16 18 ± 7 10 ± 4 17 ± 4 86 ± 14 11 ± 5 10 ± 3 13 ± 1 15 ± 5 12 ± 5
CcD18 19 ± 9 12 ± 6 17 ± 5 15 ± 2 28 ± 12 10 ± 2 15 ± 1 17 ± 6 13 ± 6
CcD20 17 ± 6 11 ± 6 19 ± 3 17 ± 3 57 ± 24 11 ± 3 12 ± 1 14 ± 4 12 ± 5
CcD25 15 ± 6 11 ± 5 18 ± 4 17 ± 2 12 ± 5 9 ± 2 11 ± 1 14 ± 4 12 ± 3
CcD33 20 ± 9 11 ± 6 17 ± 6 22 ± 2 13 ± 5 10 ± 3 12 ± 2 13 ± 4 106 ± 30
CcD34 16 ± 9 10 ± 4 16 ± 3 14 ± 2 13 ± 6 10 ± 2 12 ± 1 13 ± 4 13 ± 6
CcD35 14 ± 7 12 ± 4 15 ± 5 12 ± 1 12 ± 4 11± 3 12 ± 2 14 ± 3 12 ± 5
CcD37 15 ± 4 9 ± 3 19 ± 2 16 ± 0 12 ± 4 100 ± 0 11 ± 1 12 ± 4 11 ± 5
CcD39 14 ± 4 10 ± 5 18 ± 3 22 ± 2 14 ± 6 9 ± 2 11 ± 1 12 ± 3 12 ± 5
CcD40 16 ± 8 11 ± 5 19 ± 4 19 ± 4 12 ± 5 10 ± 2 13 ± 2 16 ± 5 13 ± 6
CcD43 20 ± 10 24 ± 14 86 ± 5 17 ± 1 13 ± 5 10 ± 3 12 ± 1 16 ± 1 14 ± 2
CcD44 15 ± 8 9 ± 4 25 ± 7 16 ± 0 12 ± 5 8 ± 1 11 ± 1 12 ± 4 11 ± 5
CcD47 16 ± 6 11 ± 6 17 ± 3 18 ± 0 12 ± 5 8 ± 2 12 ± 1 14 ± 3 11 ± 4
CcD51 15 ± 7 14 ± 5 18 ± 4 20 ± 4 11 ± 5 9 ± 2 12 ± 0 14 ± 4 12 ± 5
CcD52 16 ± 8 11 ± 7 16 ± 5 20 ± 6 11 ± 5 83 ± 4 13 ± 2 14 ± 4 12 ± 5
CcD53 19 ± 8 12 ± 6 17 ± 2 18 ± 2 12 ± 5 9 ± 2 14 ± 2 41 ± 7 11 ± 4
CcD57 17 ± 6 28 ± 18 21 ± 4 23 ± 12 32 ± 10 9 ± 2 13 ± 1 13 ± 4 12 ± 5
CcD58 18 ± 7 11 ± 5 17 ± 3 22 ± 3 34 ± 11 11 ± 2 14 ± 1 15 ± 5 13 ± 5
CcD63 15 ± 9 11 ± 5 17 ± 1 17 ± 0 29 ± 11 11 ± 5 100 ± 0 14 ± 5 12 ± 5
CcD68 43 ± 7 110 ± 11 16 ± 5 18 ± 0 13 ± 5 9 ± 2 13 ± 1 14 ± 5 11 ± 5
CcD69 14 ± 7 11 ± 6 16 ± 3 13 ± 2 12 ± 5 8 ± 3 12 ± 1 12 ± 4 11 ± 5
CcD71 15 ± 6 11 ± 5 17 ± 6 16 ± 2 13 ± 6 10 ± 2 13 ± 1 14 ± 5 13 ± 5
CcD73 19 ± 7 12 ± 7 17 ± 0 23 ± 3 15 ± 6 15 ± 7 13 ± 5 18 ± 7 13 ± 5
CcD76 13 ± 6 16 ± 8 14 ± 1 15 ± 3 15 ± 7 15 ± 7 13 ± 4 12 ± 4 13 ± 4
CcD77 14 ± 9 13 ± 4 17 ± 7 14 ± 2 15 ± 7 14 ± 6 12 ± 5 10 ± 2 13 ± 4
CcD80 16 ± 11 13 ± 4 19 ± 5 17 ± 3 30 ± 9 13 ± 5 13 ± 5 10 ± 4 13 ± 5
CcD81 16 ± 5 12 ± 4 23 ± 7 19 ± 4 22 ± 5 12 ± 5 12 ± 5 9 ± 3 11 ± 4
CcD84 17 ± 8 14 ± 7 13 ± 1 18 ± 2 29 ± 16 12 ± 5 12 ± 3 14 ± 4 13 ± 4
CcD89 17 ± 6 15 ± 1 20 ± 6 95 ± 9 14 ± 9 14 ± 5 13 ± 4 13 ± 5 13 ± 5
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CcD96 20 ± 8 14 ± 1 19 ± 7 15 ± 1 118 ± 37 12 ± 4 11 ± 4 9 ± 3 13 ± 5
CcD101 18 ± 5 12 ± 3 13 ± 4 16 ± 1 13 ± 7 12 ± 5 10 ± 3 100 ± 0 12 ± 4
CcD104 16 ± 9 14 ± 1 18 ± 7 21 ± 4 31 ± 11 11 ± 4 10 ± 3 9 ± 3 11 ± 4
CcD105 107 ± 28 14 ± 2 16 ± 8 17 ± 5 14 ± 8 13 ± 5 11 ± 4 9 ± 3 12 ± 4
CcD106 13 ± 8 16 ± 1 21 ± 11 17 ± 2 59 ± 24 13 ± 5 11 ± 4 9 ± 3 13 ± 5
CcD113 15 ± 11 16 ± 2 19 ± 9 14 ± 0 14 ± 6 108 ± 6 11 ± 4 9 ± 4 12 ± 4
CcD115 15 ± 9 16 ± 2 19 ± 9 21 ± 4 16 ± 8 12 ± 4 10 ± 4 9 ± 3 12 ± 5
CcD116 14 ± 8 14 ± 2 19 ± 5 18 ± 2 15 ± 7 12 ± 5 12 ± 5 9 ± 3 13 ± 5
CcD117 19 ± 10 16 ± 1 19 ± 8 99 ± 12 14 ± 7 13 ± 6 13 ± 5 9 ± 3 13 ± 5
CcD118 15 ± 7 14 ± 1 20 ± 9 19 ± 4 15 ± 7 111 ± 5 12 ± 4 10 ± 3 12 ± 5
CcD119 15 ± 8 16 ± 2 16 ± 9 28 ± 22 15 ± 9 12 ± 4 11± 4 12 ± 5 12 ± 4
CcD120 15 ± 8 17 ± 3 17 ± 5 23 ±7 16 ± 8 13 ± 5 12 ± 4 10 ± 3 12 ± 4
CcD122 12 ± 8 14 ± 1 17 ± 6 13 ± 1 14 ± 8 13 ± 5 12 ± 4 9 ± 2 12 ± 4
CcD124 15 ± 8 16 ± 1 19 ± 8 19 ± 4 15 ± 7 109 ± 9 11 ± 4 9 ± 3 12 ± 4
CcD126 13 ± 7 14 ± 1 16 ± 6 21 ± 3 15 ± 7 13 ± 6 11 ± 4 11 ± 4 12 ± 4
CcD129 13 ± 9 15 ± 2 21 ± 6 20 ± 2 16 ± 8 12 ± 5 14 ± 6 10 ± 2 100 ± 0
CcD130 13 ± 7 29 ± 11 108 ± 26 19 ± 2 11 ± 6 15 ± 6 12 ± 4 10 ± 4 13 ± 5
CcD131 12 ± 7 14 ± 2 17 ± 6 19 ± 3 14 ± 6 13 ± 6 11 ± 4 10 ± 3 12 ± 4
 593 
 594 
Capsular serotyping was determined by ELISA on entire heat-killed bacteria. The 595 
following sera were used: Y1C12 adsorbed anti-Cc5 (A), Cc6 ΔwbuB adsorbed anti-Cc6 596 
(B), Cc9 ΔwbuB adsorbed anti-Cc9 (C), Cc12 ΔwbtA adsorbed anti-Cc12 (D), anti-Cc4 597 
adsorbed with all human isolates except Cc4 (E), anti CcD37 adsorbed with all human 598 
isolates (F), anti CcD63 adsorbed with all human isolates (G), anti CcD101 adsorbed 599 
with all human isolates (H), and anti CcD129 adsorbed with all human isolates (I). The 600 
readout of the ELISA was absorbance but results are expressed here as percentage of 601 
reactivity calculated with respect to the absorbance value obtained for the capsular type 602 
strain. Values are the mean (± standard deviation, SD) of at least 3 independent 603 
experiments. The type strains for each capsular serovar and the strains with strong 604 
reactivities (>80%) are highlighted in dark grey. The strains presenting intermediate 605 
reactivities comprised between 30 and 60% are highlighted in light grey. 606 
nd, not determined 607 
  608 
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Table 2: Summary of capsular typing of human isolates by PCR 609 
 610 
Strain/Isolate 
PCR A 
Primers 
8244-
8245 
PCR B 
Primers 
8246-
8247 
PCR C 
Primers 
8274-
8275 
PCR D 
Primers 
8276-
8277 
PCR E 
Primers 
8278-
8279 
PCR 
ABC 
Primers 
8296-
8297 
Serovar 
Cc1 X  X   X A 
Cc2 X  X   X A 
Cc3 X  X   X A 
Cc5 X X    X A 
Cc10 X  X   X A 
Cc13 X  X   X A 
Cc15 X X    X A 
Cc21 X  X   X A 
Cc22 X  X   X A 
Cc24 X X    X A 
Cc25 X  X   X A 
Cc6  X    X B 
Cc8  X    X B 
Cc11  X    X B 
Cc16  X    X B 
Cc17  X    X B 
Cc18  X    X B 
Cc23  X    X B 
Cc9   X   X C 
Cc14   X   X C 
Cc19   X   X C 
Cc20   X   X C 
Cc7    X   D 
Cc12    X   D 
Cc4     X  E 
 611 
PCR positive results are represented by X. 612 
  613 
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Table 3: Interpretation of PCR typing results 614 
 615 
 PCR A 
Primers: 
8244-8245 
PCR B 
Primers: 
8246-8247
PCR C 
Primers: 
8274-8275
PCR D 
Primers: 
8276-8277
PCR E 
Primers: 
8278-8279 
PCR ABC
Primers: 
8296-8297
Serovar A 
X     X 
X X    X 
X  X   X 
 
Serovar B 
 
 X    X 
 
Serovar C 
 
  X   X 
 
Serovar D 
 
   X   
Serovar E     X  
 616 
PCR positive results are represented by X. 617 
 618 
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